Clopidogrel, Ticagrelor, Prasugrel and Glycoprotein inhibitors (abciximab, eptifibatide, tirofiban) are the main mortality reducing drugs. Moreover, Statins have demonstrated clear benefits in morbidity and mortality in the secondary prevention of coronary artery disease.